APA (7th ed.) Citation

U, F., J, K., D, S., O, E., C, C., PS, P., . . . J, G. (2022). Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: An open-label, blinded-outcome, randomised non-inferiority trial. Lancet (London, England), 400(10346), 104. https://doi.org/10.1016/S0140-6736(22)00537-2

Chicago Style (17th ed.) Citation

U, Fischer, et al. "Thrombectomy Alone Versus Intravenous Alteplase Plus Thrombectomy in Patients with Stroke: An Open-label, Blinded-outcome, Randomised Non-inferiority Trial." Lancet (London, England) 400, no. 10346 (2022): 104. https://doi.org/10.1016/S0140-6736(22)00537-2.

MLA (9th ed.) Citation

U, Fischer, et al. "Thrombectomy Alone Versus Intravenous Alteplase Plus Thrombectomy in Patients with Stroke: An Open-label, Blinded-outcome, Randomised Non-inferiority Trial." Lancet (London, England), vol. 400, no. 10346, 2022, p. 104, https://doi.org/10.1016/S0140-6736(22)00537-2.